Infection of the rhesus monkey with simian immunodeficiency virus of macaques (SlVmac) was employed to explore the early immune events associated with the initial containment of an acute AIDS virus infection. In nine rhesus monkeys infected intravenously with uncloned SlVmac strain 251, high-level p27 plasma antigenemia was usually detected transiently from approximately day 7 through day 21 following virus inoculation. SlVmac replication in lymph nodes measured by in situ RNA hybridization closely paralleled the time course and magnitude of viremia. The containment of SIVmac spread by 3 to 4 weeks following infection suggests an efficient, early immune control of this virus infection. Anti-SlVmac antibodies were first detected in the blood at approximately day 14. At the time antigenemia was decreased or cleared, SIVmac neutralizing antibodies were present. A rise in circulating and lymph node CD8+ T cells also occurred coincident with the clearance of antigenemia and persisted thereafter. These CD8+ lymphocytes in lymph nodes had increased expression of both major histocompatibility complex class II and the adhesion molecule LFA-1; they also demonstrated decreased expression of the naive T-cell-associated CD45RA molecule. SlVmac-specific cytotoxic T-lymphocyte precursors were detected in both blood and lymph node by 7 days post-virus inoculation. These studies indicate that both virus-specific humoral and cellular immune mechanisms in blood and lymph node are associated with the clearance of viremia that occurs within the first month of infection of rhesus monkeys with SlVmac.
Infection of the rhesus monkey with simian immunodeficiency virus of macaques (SlVmac) was employed to explore the early immune events associated with the initial containment of an acute AIDS virus infection. In nine rhesus monkeys infected intravenously with uncloned SlVmac strain 251, high-level p27 plasma antigenemia was usually detected transiently from approximately day 7 through day 21 following virus inoculation. SlVmac replication in lymph nodes measured by in situ RNA hybridization closely paralleled the time course and magnitude of viremia. The containment of SIVmac spread by 3 to 4 weeks following infection suggests an efficient, early immune control of this virus infection. Anti-SlVmac antibodies were first detected in the blood at approximately day 14. At the time antigenemia was decreased or cleared, SIVmac neutralizing antibodies were present. A rise in circulating and lymph node CD8+ T cells also occurred coincident with the clearance of antigenemia and persisted thereafter. These CD8+ lymphocytes in lymph nodes had increased expression of both major histocompatibility complex class II and the adhesion molecule LFA-1; they also demonstrated decreased expression of the naive T-cell-associated CD45RA molecule. SlVmac-specific cytotoxic T-lymphocyte precursors were detected in both blood and lymph node by 7 days post-virus inoculation. These studies indicate that both virus-specific humoral and cellular immune mechanisms in blood and lymph node are associated with the clearance of viremia that occurs within the first month of infection of rhesus monkeys with SlVmac.
The early virologic and immunologic events following infection may have important consequences for the eventual clinical course of human immunodeficiency virus (HIV)-induced disease. A picture of the immunopathogenic events in the acutely HIV-infected individual is beginning to emerge. At the time of clinical presentation with fever, lethargy, pharyngitis, and skin rash, the acutely infected person has readily measurable plasma viral antigen reflecting a high viral replication. The early development of virus-specific cytotoxic T lymphocytes (CTL) and an emerging neutralizing antibody response appear to correlate with the clearance of this plasma antigenemia as the individual enters a period of clinical latency (2) (3) (4) 21) . Because the acutely infected person comes to clinical attention weeks or even months following viral exposure if at all, it is difficult to study the immunologic mechanisms responsible for the clearance of this acute viremia in humans.
Despite the apparent clearance of plasma antigen soon after acute infection, important virologic events appear to be ongoing in the clinically asymptomatic, HIV-infected individual. Lymph nodes (LNs) have been implicated as a reservoir of HIV infection (7, 18, 19) and important in virus spread (19, 20) . In situ DNA PCR studies have shown a higher proviral load in LNs than in the blood of these individuals (6, 12) . In situ assessments of viral RNA (vRNA), an indicator of actively replicating virus, also suggest a high degree of viral replication in these LNs (12) . It is important to determine the nature of the virus-specific immune responses in the LNs of infected individuals since it is these responses that should contain the spread of HIV. These regional immune responses to replicating virus may be of particular importance in the setting of acute infections.
The rhesus monkey infected with simian immunodeficiency virus of macaques (SIVmac) provides a unique system for studying the immunopathogenesis of AIDS. SIVmac, a lentivirus with genetic homology to the HIVs, infects CD4-bearing lymphocytes and macrophages and induces a disease in macaque monkeys with significant similarities to HIV-induced disease in humans (5, 9 SIVmac neutralizing antibodies were measured in 96-well plates as previously described (11) CTL assays. PBL of a rhesus monkey which expressed the MHC class I allele Mamu-A *01 were isolated from heparinized blood by density gradient centrifugation over Ficoll-Hypaque (Ficopaque; Pharmacia Chemical Co., Piscataway, N.J.). LN lymphocytes were simultaneously obtained from the same monkey by the method described above. These cells were cultured for 3 days at 106 cells per ml in concanavalin A (5 ,ug/ml) or at 2.5 x 106 cells per ml in synthetic SIV Gag peptides (5 ,ug/ml) and human recombinant interleukin 2 (400 U/ml). These cells were then assayed for their ability to lyse autologous B-lymphoblastoid cell lines which were incubated with SIV Gag peptides as described previously (10) .
In situ hybridization of SIV RNA. LN biopsies were fixed in 10% neutral buffered formalin and embedded in paraffin. Five-micrometer-thick sections were placed on slides coated with 3-amino-propyl-triethosilane. Four As a positive control, cytospin preparations of peripheral blood mononuclear cells infected with SIVmac were hybridized with the same probe. As a negative control, one section per LN for each time point was hybridized with a radiolabeled sense-strand probe. The sections were examined with an Axiophot Zeiss microscope equipped with epiluminescent illumination. Cells with at least 20 silver grains were scored as vRNA positive. This corresponded to a sixfold excess of silver grains over background.
Statistical analysis. Scatterplots were constructed from the relative or absolute number of lymphocytes over time, together with their mean values at all time points where >2 datum points were collected (see Fig. 2, 3, and 5 ). The plots were visually compared for qualitative differences and similarities in the time course patterns. Statistically significant differences (P < 0.05) in expression of cell surface molecules on CD8+ lymphocytes between time points (see Fig. 6 ) were detected with a random analysis of variance model and were compared on a pairwise basis by the least significant difference test. (Fig. 1) . In the two monkeys in which p27 antigenemia was still detectable after day 29, the level of antigenemia had declined 5-to 10-fold from its peak level.
RESULTS
Anti (Fig. 1) . Thus, the emergence of an anti-SIVmac antibody response correlated with the decrease or clearance of plasma antigenemia in these animals. When they were assayed for virus neutralization, neutralizing antibody titers were detected at low levels within the first 17 days in four of nine animals, and all had significant neutralizing antibody titers by days 29 to 34 ( Table 1 ). The magnitude of the neutralizing antibody response did not correlate with magnitude or duration of viral antigenemia.
A CD8+ lymphocytosis occurred coincident with the onset of plasma antigenemia in the monkeys. Cellular immune responses were then characterized in these acutely infected monkeys. Most monkeys experienced a lymphopenia coincident with the onset of plasma antigenemia. Absolute numbers of both CD4+ and CD8+ PBL decreased during antigenemia. Following the period of antigenemia, percent CD4+ PBL declined while percent CD8+ PBL increased (Fig. 2) . However, during this time, absolute PBL number increased so that by 30 to 35 CD4+ and CD8+ lymphopenia corresponds with plasma antigenemia followed by a CD8+ lymphocytosis. Absolute numbers of CD4+ (A) and CD8+ (B) lymphocytes were determined for nine monkeys before or immediately after they were experimentally inoculated with SIVmac.
had nearly returned to normal despite a decrease in percent CD4+ PBL. In contrast, both the absolute number and the percent CD8+ PBL increased during this period following antigenemia (Fig. 3) .
SIVmac RNA expression in LN T cells paralleled p27 antigenemia in the acutely infected monkeys. Previous findings suggest that LNs of AIDS virus-infected individuals are important reservoirs for virus (7, (18) (19) (20) and contain higher virus loads than blood mononuclear cells (6, 12) . We, therefore, sought to assess the extent of viral replication in LNs during the period immediately following SIVmac infection. LNs from three monkeys were assessed by in situ hybridization with an SIVmac probe for vRNA expression. LNs removed prior to SIVmac infection contained no vRNA sequences. Low numbers of productively infected cells appeared as early as 5 to 8 days postinfection (Table 2 and Fig. 4B ). Monkey 467 had the highest number of productively infected cells with 90 or more positive cells per field. In addition, the signal intensity was greatest in this animal with >50 silver grains per cell. The two other animals contained fewer positive cells (14 to 25 per field), and the intensity of signal was lower. They exhibited 25 to 40 silver grains per cell. In all animals, the vRNA-positive cells had the morphologic appearance of lymphocytes and macrophages and were mainly in the extrafollicular parenchyma and sinuses. Several germinal centers or mantle zones also contained one or two vRNA-positive cells despite the small, inactive state of these germinal centers.
In biopsies taken 21 days after infection, the distribution of productively infected cells remained the same (Table 2 and Fig. 4C) . However, the number of infected cells declined in all monkeys. In addition, in animal 467, the hybridization signal per cell decreased. LNs sampled 30 to 40 days postinfection were almost completely free of vRNA-positive cells (Table 2) . Positive cells were not seen in many of the four sections examined. On some cutting levels, however, a few productively infected cells (one to three) could be visualized either in the extrafollicular parenchyma or in the germinal centers (Fig.  4D) . The rapid emergence and equally rapid down-regulation of viral replication in these LN cells paralleled to a remarkable degree the plasma antigenemia in these animals ( Table 2) .
T-lymphocyte phenotypic changes in LNs paralleled those in PBL following acute SlVmac infection. To assess T-lymphocyte changes in peripheral LNs of these acutely infected animals, phenotypic changes in the T-cell compartments of these nodes were assessed. Coincident with the clearance of plasma antigen, a drop in the percent CD4+ LN T cells together with a rise in the percent CD8+ LN T cells was documented (Fig. 5) . Since lymphadenopathy was clinically apparent in these animals by approximately 1 week following SIVmac infection, this rise in percent CD8+ cells probably represented an absolute increase in LN CD8+ cells.
Phenotype changes in LN CD8+ cells correlated with the clearance of p27 antigenemia in the acutely infected monkeys. These observations indicated that an increase in circulating and LN CD8+ T cells correlated with the clearance of acute antigenemia in this cohort of monkeys. We sought to characterize further this CD8+ lymphocyte population by phenotypic analysis. PBL were examined before, during, and following antigenemia; assessed were their state of activation (MHC class II expression), memory status (CD45RA expression), and adhesion potential (CDlla-CD18 expression) (Fig. 6) . Interestingly, only minimal changes in PBL CD8+ lymphocyte expression of MHC class II and CDlla-CD18 occurred coincident with the clearance of plasma antigenemia. However, in T cells from LNs of these animals, the expression of both MHC class II and CDlla-CD18 molecules was increased on CD8+ lymphocytes following antigenemia. Moreover, the expression of CD45RA was decreased on peripheral blood and LN CD8+ T cells following antigenemia.
SlVmac Gag-specific CTL precursors were demonstrable in LNs and PBL of the infected animals by day 7 following infection. These studies indicated the emergence of a CD8+ lymphocyte population in the LNs and peripheral blood of the acutely infected animals coincident with the clearance of plasma antigenemia and replicating virus in LNs. The phenotype was consistent with a cytotoxic effector cell (13, 22) . We sought to document the time course for the generation of SIVmac-specific CTL in these acutely infected animals. We have previously shown that Gag-and Nef-specific CTL were demonstrable in PBL by 14 days following infection, while CTL effector precursors were seen in PBL of acutely SIVmacinfected rhesus monkeys by 4 to 6 days following virus infection (23) . These studies were done in monkeys with a defined MHC class I haplotype. We have previously shown that rhesus monkeys expressing the MHC class I molecule Mamu-A *01 develop SIVmac Gag-specific CTL that recognize a 9-aminoacid epitope of the Gag protein termed pllC. One Mamu-A*01+ rhesus monkey was selected from this cohort of nine animals for prospective evaluation of SIVmac Gag-specific CTL activity in peripheral blood and LN T-cell populations.
We assessed both lectin-and p1l-stimulated T cells from this animal on a weekly basis following infection for CTL activity.
In both peripheral blood and LNs, pliC-stimulated T cells from this animal exhibited pl1-specific effector function by day 7 following infection. By day 14 after infection, both pliC-and (Table 3) . Thus, CD8+ CTL precursors were demonstrable not only in peripheral blood but also in LN T-cell populations within the first week following SIVmac infection. Moreover, SIVmac Gag-specific CTL were present in both LN and PBL T-cell populations at a high enough frequency to be detected without specific peptide restimulation by 14 days after infection. The emergence of this effector T-cell response correlated in this animal with the clearance of plasma antigenemia and viral replication in LNs.
DISCUSSION
Events following acute intravenous infection of rhesus monkeys with SIVmac parallel those seen in acutely HIV-infected humans who have been studied. Within weeks of infection, lymphadenopathy and skin rash are seen in both. Moreover, acute antigenemia occurs within days to weeks following SIVmac or HIV infection. In both, virus-specific antibodies (14) . The sudden disappearance of vRNA-expressing cells in the LNs of the rhesus monkeys in the present study and the coincident fall in plasma antigenemia suggest that the early immune response against the infecting AIDS virus may be quite effective. It will be important to determine whether preexisting vaccine-induced AIDS virus-specific immune responses or early antiviral therapy can accelerate the containment of this early viral infection.
The clearance of plasma viral antigenemia and the disappearance of vRNA in LN cells correlate with both the emergence of anti-SIVmac antibodies and an SIVmac-specific CTL response. Early-appearing SIVmac-specific antibodies, which usually preceded neutralizing antibodies, may promote viral immune complex formation with complement and lead to virus clearance through the mononuclear phagocytic system independent of the classical neutralizing antibodies (1, 17) . Previously, we have shown that SIVmac-specific CTL precursors appear in PBL within days after experimental infection (23) . In addition, an activated CD8+ lymphocyte appears in LNs by 2 months after infection (16) . In the present study, we show that the emergence of these cellular responses correlates with the clearance of viremia and suppression of virus replication. While these studies do not distinguish between the contribution made by cellular immunity and that made by humoral immunity in the control of this early burst of viral replication, they do provide further evidence for the likely importance of the cell-mediated immune response in clearing the early AIDS virus infection.
Distinct SIVmac isolates may have very different tropisms and cause disease with different clinical courses in rhesus monkeys. Similarly, the dose or route of virus inoculation in the monkeys may also dramatically alter the virologic and immunologic events following initial infection. The SIVmacrhesus monkey model provides a powerful system for exploring issues such as these in the immunopathogenesis of AIDS. The SIVmac-infected rhesus monkey will also provide an extremely useful model for assessing the impact of immunologic and antiretroviral interventions on the acute phase of AIDS virus infection.
